Clinical Application of Interferon-γ Release Assays for the Prevention of Tuberculosis in Countries with Low Incidence
Despite global efforts to control tuberculosis (TB) the estimated number of people who developed TB worldwide increased to an all-time record of more than 10 million in 2015. The goal of the World Health Organization (WHO) to reduce the global incidence of TB to less than 100 cases per million by 20...
Saved in:
Main Authors: | Christoph Lange (Author), Anna M. Mandalakas (Author), Barbara Kalsdorf (Author), Claudia M. Denkinger (Author), Martina Sester (Author) |
---|---|
Format: | Book |
Published: |
Case Western Reserve University,
2017-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Usefulness of interferon-γ release assay for the diagnosis of latent tuberculosis infection in young children
by: Ki Wook Yun, et al.
Published: (2016) -
The Benefit of Interferon-Gamma Release Assay for Diagnosis of Extrapulmonary Tuberculosis
by: Cleopas Martin Rumende, et al.
Published: (2018) -
Infliximab Therapy Leading to Pulmonary Tuberculosis in a Patient With Negative Interferon γ Release Assay (IGRA)-Based QuantiFERON Gold Test
by: Soni Parita MD, et al.
Published: (2017) -
Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays
by: Robert J. Blount, et al.
Published: (2016) -
Usefulness of interferon-γ release assay for the diagnosis of sputum smear-negative pulmonary and extra-pulmonary TB in Zhejiang Province, China
by: Lei Ji, et al.
Published: (2017)